Non-obstructive hypertrophic cardiomyopathy
Clinical trials for Non-obstructive hypertrophic cardiomyopathy explained in plain language.
Never miss a new study
Get alerted when new Non-obstructive hypertrophic cardiomyopathy trials appear
Sign up with your email to follow new studies for Non-obstructive hypertrophic cardiomyopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new pill help hearts thickened by hypertrophic cardiomyopathy?
Disease control CompletedThis trial tests an experimental drug called HRS-1893 in people with non-obstructive hypertrophic cardiomyopathy, a condition where the heart muscle thickens and makes it harder for the heart to pump blood. The study will see if the drug is safe and whether it can improve exercis…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Heart drug mavacamten tested for long-term safety in HCM patients
Disease control CompletedThis study looked at the long-term safety of the drug mavacamten in adults with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. About 314 people who had already finished earlier studies took part. The goal was to track side effects over time, not to cure…
Matched conditions: NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase 2/3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC